(Q43580944)

24 November 2017

title

High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma (English)

1 reference

24 November 2017

0 references

Liang Han

1

1 reference

24 November 2017

Bin Jiang

2

1 reference

24 November 2017

Hao Wu

3

1 reference

24 November 2017

Xudong Wang

4

1 reference

24 November 2017

Xiaojun Tang

5

1 reference

24 November 2017

Jianfei Huang

6

1 reference

24 November 2017

Jin Zhu

7

1 reference

24 November 2017

publication date

25 January 2012

1 reference

24 November 2017

1 reference

24 November 2017

volume

29

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

2466-2472

1 reference

24 November 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Radiotherapy for laryngeal squamous cell carcinoma: current standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

The molecular biology of leukocyte chemoattractant receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

CXCL8 and its cognate receptors in melanoma progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Delayed wound healing in CXCR2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

CXCR2-Dependent Endothelial Progenitor Cell Mobilization in Pancreatic Cancer Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0152-1

World Health Organization classification of tumours: pathology and genetics of head and neck tumours

21 January 2018

1 reference

12 December 2020

Chemokines in human colorectal carcinoma

1 reference

12 December 2020

Chemokine receptors and their role in inflammation and infectious diseases

1 reference

12 December 2020

The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor

1 reference

12 December 2020

Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma

1 reference

12 December 2020

Characterization of two high affinity human interleukin-8 receptors

1 reference

12 December 2020

Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S12032-011-0152-1

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1004372244

0 references

1 reference